First-line osimertinib in patients with epidermal growth factor receptor–mutant non–small-cell lung cancer and with a coexisting low allelic fraction of Thr790Met
Titel:
First-line osimertinib in patients with epidermal growth factor receptor–mutant non–small-cell lung cancer and with a coexisting low allelic fraction of Thr790Met
Auteur:
Majem, Margarita Sullivan, Ivanna Viteri, Santiago López-Vivanco, Guillermo Cobo, Manuel Sánchez, José M. García-González, Jorge Garde, Javier Sampayo, Miguel Martrat, Griselda Malfettone, Andrea Karachaliou, Niki Molina-Vila, Miguel A. Rosell, Rafael